Skip to content
In English |
En español
Search
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -10 of 14
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
8/1/1997
1.
Phase III Randomized, Double-Blind Study of 9-CRA Topical Gel vs Vehicle Gel for AIDS-Related Kaposi's Sarcoma (Summary Last Modified 08/97)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Completed
18 and over
Pharmaceutical / Industry
LIGAND-L1057T-31
NCI-V96-0867
Last Modified:
4/1/1998
 
First Published:
12/1/1997
2.
Phase III Study of 9-cis-Retinoic Acid versus Tretinoin in Patients with Newly Diagnosed Acute Promyelocytic Leukemia (Summary Last Modified 04/98)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
18 and over
Pharmaceutical / Industry
LIGAND-L1057-77
NCI-V97-1291
Last Modified:
4/1/1995
3.
Phase I/II Pilot Study of Topical 9-CRA for Cutaneous Kaposi's Sarcoma in HIV-Positive Patients (Summary Last Modified 04/95)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Closed
18 and over
Pharmaceutical / Industry
MSKCC-94087A1
NCI-V94-0595
Last Modified:
12/1/1995
4.
Phase I/II Pilot Study of Topical 9-CRA for Cutaneous T-Cell Lymphoma (Summary Last Modified 12/95)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Closed
18 and over
Pharmaceutical / Industry
MDA-DM-94075
MSKCC-94098, NCI-V95-0620
Last Modified:
7/1/1997
5.
Phase I/II Study of 9-CRA/IFN-A for Metastatic or Recurrent Renal Cell Carcinoma (Summary Last Modified 07/97)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Closed
16 and over
CAN-NCIC-IND88
NCI-V95-0754, IND88
Last Modified:
4/1/1996
6.
Phase II Study of 9-CRA for Locally Advanced, Inoperable, or Recurrent Carcinoma of the Cervix (Summary Last Modified 04/96)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
no age specified
NCI
AECM-1199508304
NCI-T95-0063H, T95-0063
Last Modified:
10/1/1997
7.
Phase II Study of Oral 9-cis-Retinoic Acid for AIDS-Related Kaposi's Sarcoma (Summary Last Modified 10/97)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
Pharmaceutical / Industry
LIGAND-L1057-28
NCI-V96-0974
Last Modified:
4/1/1998
8.
Phase II Study of 9-cis-Retinoic Acid/Carboplatin in Carboplatin-Resistant Ovarian Cancer (Summary Last Modified 04/98)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
Pharmaceutical / Industry
LIGAND-L1057-32
NCI-V96-1051
Last Modified:
8/1/1997
9.
Phase II Study of Oral 9-cis-Retinoic Acid for Advanced Hormone-Refractory Prostate Cancer (Summary Last Modified 08/97)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
Pharmaceutical / Industry
LIGAND-L1057-33
NCI-V96-1052
Last Modified:
4/1/2001
10.
Phase II Study of Oral 9-cis-Retinoic Acid for AIDS-Related Kaposi's Sarcoma (Summary Last Modified 04/2001)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
NCI
AMC-002
NCI-T96-0042H, AMC-002
Select All on One Page
1
2
Next >
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute